共 50 条
- [1] Response-adapted volume de-escalation (RAVD) of radiotherapy (RT) using induction chemotherapy (IC) in locally advanced head and neck squamous cell cancer (LA-HNSCC)JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Villaflor, Victoria MeucciCohen, Ezra E. W.Melotek, James M.Brisson, Ryan J.Karrison, TheodoreBlair, Elizabeth A.Portugal, LouisStenson, KerstinDe Souza, Jonas A.Langerman, AlexanderSeiwert, Tanguy Y.Vokes, Everett E.Haraf, Daniel J.
- [2] Response of chemoradiation therapy after induction chemotherapy failure in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Lim, YoojooKeam, BhumsukKoh, YoungilLee, Kyung-HunKim, Tae MinLee, Se-HoonHah, Jeong-HunKwon, Tack-KyunKim, Dong-WanWu, Hong-GyunSung, Myung-WhunHeo, Dae SeogKim, Kwang Hyun
- [3] Paclitaxel in combination with anti-EGFR therapy as induction chemotherapy for patients unfit for cisplatin with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)ANNALS OF ONCOLOGY, 2018, 29 : 383 - 383Marin, J. A.Oliva Bernal, M.Plana Serrahima, M.Ferrer, M.Vilarino Quintela, N.Vazquez, S.Vilajosana, E.Lozano, A.Nogues, J.Mari, A.Bermejo, O.Mesia Nin, R.Taberna Sanz, M.
- [4] Pembrolizumab and radiotherapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with contraindication to cisplatin therapyANNALS OF ONCOLOGY, 2019, 30Sheth, S.Bauman, J. R.Deal, A.Chera, B.Shen, C.Galloway, T.Hackman, T.Blumberg, J.Yarbrough, W.Weissler, M.Hilliard, C.Mehra, R.Grilley-Olson, J.Weiss, J.
- [5] A randomized, multicenter, open phase II study of cetuximab with docetaxel, cisplatin as induction chemotherapy in unresectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC)JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Koh, YoungilLee, Keun-WookKim, Sung-BaePark, Kyong HwaShin, Sang WonKang, Jin HyoungKeam, BhumsukLee, Se-HoonHeo, Dae Seog
- [6] Retrospective analysis of the addition of cetuximab to induction chemotherapy (IC) with docetaxel, cisplatin, and 5-fluorouracil (TPF-C) for locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC)JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Kuperman, D. I.Nussenbaum, B.Thorstad, W.Haughey, B.Lewis, J.Adkins, D.
- [7] Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Uppaluri, RavindraZolkind, PaulLin, TianxiangNussenbaum, BrianJackson, Ryan S.Rich, JasonPipkorn, PatrikPaniello, RandalThorstad, WadeMichel, LorenMudianto, TennyOppelt, Peter JohnWildes, Tanya MaryaDunn, Gavin P.Piccirillo, Jay F.Kallogjeri, DonnaRodig, ScottHagemann, Ian S.Chernock, RebeccaAdkins, Douglas
- [9] Factors associated with hospitalization in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with definitive chemoradiation (CRT).JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Park, Soo J.Parikh, MiliHarrington, JoanneHeppner, PiaMcCarthy, KellyCrandall, BaileyWong-Sefidan, Ida
- [10] Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Garcia, Enrique SanzZou, JinfengAvery, LisaSpreafico, AnnaWaldron, JohnGoldstein, David PaulHansen, Aaron RichardCho, Johnde Almeida, John R.Hope, AndrewHosni, AliHahn, EzraPerez-Ordonez, BayardoZhao, ZhenSmith, Christopher GarethZheng, YangqiaoRosenfeld, NitzanSingaravelan, NittushaBratman, Scott VictorSiu, Lillian L.